Bigespas LTD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia (NCT07251023) | Bigespas LTD | 2025-11-20 |
| DMB-I in the Treatment of Alzheimer Type Dementia (NCT06292351) | Bigespas LTD | 2023-12-27 |
Track Bigespas LTD automatically
Every clearance here is in the API, with alerts when new ones post.